Publication: 2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies
| dc.contributor.author | Qayed W. S. | |
| dc.contributor.author | Hassan M. A. | |
| dc.contributor.author | Şenol H. | |
| dc.contributor.author | Taslimi P. | |
| dc.contributor.author | Aboul-Fadl T. | |
| dc.date.accessioned | 2025-11-13T21:36:29Z | |
| dc.date.issued | 2025-11-01 | |
| dc.identifier.citation | Qayed W. S., Hassan M. A., Şenol H., Taslimi P., Aboul-Fadl T., "2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies", RSC MEDICINAL CHEMISTRY, cilt.16, sa.11, ss.1-25, 2025 | |
| dc.identifier.issn | 2632-8682 | |
| dc.identifier.issue | 11 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12645/41359 | |
| dc.identifier.volume | 16 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Eczacılık | |
| dc.subject | Meslek Bilimleri | |
| dc.subject | Farmasötik Kimya | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Pharmacology and Therapeutics | |
| dc.subject | Professional Sciences | |
| dc.subject | Pharmaceutical Chemistry | |
| dc.subject | Health Sciences | |
| dc.subject | Klinik Tıp (Med) | |
| dc.subject | Yaşam Bilimleri (Life) | |
| dc.subject | Farmakoloji ve Toksikoloji | |
| dc.subject | Farmakoloji ve Eczacılık | |
| dc.subject | Clinical Medicine (Med) | |
| dc.subject | Life Sciences (Life) | |
| dc.subject | Pharmacology & Toxicology | |
| dc.subject | Pharmacology & Pharmacy | |
| dc.subject | Farmakoloji | |
| dc.subject | Farmakoloji, Toksikoloji ve Eczacılık (çeşitli) | |
| dc.subject | Genel Farmakoloji, Toksikoloji ve Eczacılık | |
| dc.subject | Farmakoloji (tıbbi) | |
| dc.subject | İlaç Rehberleri | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Pharmacy | |
| dc.subject | Pharmacology | |
| dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
| dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
| dc.subject | Pharmacology (medical) | |
| dc.subject | Drug Guides | |
| dc.subject | Life Sciences | |
| dc.title | 2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| local.avesis.id | c1333b2e-9980-4776-96dd-24a60600b9be |